Status:
COMPLETED
Safety and Efficacy of Paramedic Treatment of Regular Supraventricular Tachycardia
Lead Sponsor:
Barts & The London NHS Trust
Collaborating Sponsors:
London Ambulance Service NHS Trust
Conditions:
Supraventricular Tachycardia
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Supraventricular tachycardia (SVT) is a term describing any rhythm coming from the top half of the heart. Although atrial fibrillation is the commonest cardiac arrhythmia, regular SVT's are also commo...
Eligibility Criteria
Inclusion
- Inclusion Patients presenting with regular narrow complex tachycardia on 12 lead ECG
- Exclusion Age \< 16 years Already enrolled in the study or another research study Syncope or blackout Sinus tachycardia ECG evidence of myocardial infarction Broad Complex tachycardia A history of illicit drug use within the previous 24 hours A history of structural or ischaemic heart disease Inability or unwillingness to give consent Pregnancy Failure to obtain intravenous access Hypotension - defined as a systolic blood pressure of \<100 systolic Contraindications to Adenosine injection Heart transplant patients Patients on dipyridamole Patients on regular asthma inhalers Obvious atrial flutter
Exclusion
Key Trial Info
Start Date :
December 5 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT02216240
Start Date
December 5 2010
End Date
January 1 2015
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Trust
London, United Kingdom, EC1A 7BE